The Metabolic Outcomes of Growth Hormone Treatment in Children Are Gender Specific

Overview

Journal Endocr Connect

Specialty Endocrinology

Date 2018 Jun 22

PMID 29925523

Citations 2

Authors

Alessandro Ciresi

Stefano Radellini

Valentina Guarnotta

Maria Grazia Mineo

Carla Giordano

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the impact of gender on the clinical and metabolic parameters in prepubertal growth hormone deficiency (GHD) children at diagnosis and during GH treatment (GHT).

Design: The data of 105 prepubertal children (61 males, 44 females, mean age 6.8 ± 0.7 years) affected by idiopathic GHD were retrospectively evaluated.

Methods: Body height, BMI, waist circumference (WC), IGF-I, HbA1c, lipid profile, fasting and after-OGTT glucose and insulin levels, insulin sensitivity and secretion indices were evaluated at baseline and after 24 months of GHT.

Results: At baseline, no significant difference was found in all clinical, hormonal and metabolic parameters between males and females. After 24 months of GHT, both males and females showed a significant increase in height (both < 0.001), BMI (both < 0.001), WC ( < 0.001 and = 0.004, respectively), IGF-I (both < 0.001), fasting glucose ( < 0.001 and = 0.001, respectively), fasting insulin (both < 0.001) and Homa-IR (both < 0.001), with a concomitant significant decrease in insulin sensitivity index (ISI) (both < 0.001) and oral disposition index (DIo) ( = 0.001 and < 0.001, respectively). At 24 months of GHT, females showed significantly higher BMI ( = 0.027), lower ISI ( < 0.001) and DIo ( < 0.001), in concomitance with a significant greater change from baseline to 24 months of BMI ( = 0.013), WC ( < 0.001), ISI ( = 0.002) and DIo ( = 0.072), although the latter does not reach statistical significance.

Conclusions: Twenty-four months of GHT in prepubertal children leads to different metabolic outcomes according to gender, with a greater reduction in insulin sensitivity in females, regardless of auxological and hormonal parameters. Therefore, prepubertal GHD females should probably need a more proper monitoring in clinical practice.

Citing Articles

Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004-2015).

Ben-Ari T, Chodick G, Shalev V, Goldstein D, Gomez R, Landau Z Front Pediatr. 2021; 9:711979.

PMID: 34490167 PMC: 8418062. DOI: 10.3389/fped.2021.711979.

Meta-analysis of metabolic changes in children with idiopathic growth hormone deficiency after recombinant human growth hormone replacement therapy.

Yuan Y, Zhou B, Liu S, Wang Y, Wang K, Zhang Z Endocrine. 2020; 71(1):35-46.

PMID: 32740695 DOI: 10.1007/s12020-020-02435-w.

References

Amiel S, Caprio S, Sherwin R, Plewe G, Haymond M, Tamborlane W . Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab. 1991; 72(2):277-82. DOI: 10.1210/jcem-72-2-277. View

Radetti G, Pasquino B, Gottardi E, Contadin I, Rigon F, Aimaretti G . Insulin sensitivity in growth hormone-deficient children: influence of replacement treatment. Clin Endocrinol (Oxf). 2004; 61(4):473-7. DOI: 10.1111/j.1365-2265.2004.02113.x. View

Canete R, Valle M, Martos R, Sanchez-Carrion A, Canete M, van Donkelaar E . Short-term effects of GH treatment on coagulation, fibrinolysis, inflammation biomarkers, and insulin resistance status in prepubertal children with GH deficiency. Eur J Endocrinol. 2012; 167(2):255-60. DOI: 10.1530/EJE-12-0214. View

Leung K, Doyle N, Ballesteros M, Sjogren K, Watts C, Low T . Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci U S A. 2003; 100(3):1016-21. PMC: 298718. DOI: 10.1073/pnas.0337600100. View

Ciresi A, Amato M, Pivonello R, Nazzari E, Grasso L, Minuto F . The metabolic profile in active acromegaly is gender-specific. J Clin Endocrinol Metab. 2012; 98(1):E51-9. DOI: 10.1210/jc.2012-2896. View

Veldhuis J, Patrie J, Brill K, Weltman J, Mueller E, Bowers C . Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like growth hormone secretion in healthy middle-aged and older adults. J Clin Endocrinol Metab. 2004; 89(12):6291-6. DOI: 10.1210/jc.2004-0644. View

. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab. 2000; 85(11):3990-3. DOI: 10.1210/jcem.85.11.6984. View

Burman P, Johansson A, Siegbahn A, Vessby B, Karlsson F . Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab. 1997; 82(2):550-5. DOI: 10.1210/jcem.82.2.3776. View

Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C . Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Endocrinology. 1998; 139(5):2272-7. DOI: 10.1210/endo.139.5.5990. View

10.

Utzschneider K, Prigeon R, Faulenbach M, Tong J, Carr D, Boyko E . Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care. 2008; 32(2):335-41. PMC: 2628704. DOI: 10.2337/dc08-1478. View

11.

Matsuda M, DeFronzo R . Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22(9):1462-70. DOI: 10.2337/diacare.22.9.1462. View

12.

Johansson A . Gender difference in growth hormone response in adults. J Endocrinol Invest. 1999; 22(5 Suppl):58-60. View

13.

Birzniece V, Ho K . Sex steroids and the GH axis: Implications for the management of hypopituitarism. Best Pract Res Clin Endocrinol Metab. 2017; 31(1):59-69. DOI: 10.1016/j.beem.2017.03.003. View

14.

Kuromaru R, Kohno H, Ueyama N, Hassan H, Honda S, Hara T . Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J Clin Endocrinol Metab. 1998; 83(11):3890-6. DOI: 10.1210/jcem.83.11.5261. View

15.

Ciresi A, Amato M, Giordano C . Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment. J Endocrinol Invest. 2014; 38(3):351-9. DOI: 10.1007/s40618-014-0184-4. View

16.

Hull K, Harvey S . GH as a co-gonadotropin: the relevance of correlative changes in GH secretion and reproductive state. J Endocrinol. 2002; 172(1):1-19. DOI: 10.1677/joe.0.1720001. View

17.

Salerno M, Esposito V, Farina V, Radetti G, Umbaldo A, Capalbo D . Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study. J Clin Endocrinol Metab. 2006; 91(4):1288-95. DOI: 10.1210/jc.2005-0981. View

18.

Saenger P . Metabolic consequences of growth hormone treatment in paediatric practice. Horm Res. 2000; 53 Suppl 1:60-9. DOI: 10.1159/000053207. View

19.

Anderson M . Use of the Greulich-Pyle "Atlas of Skeletal Development of the Hand and Wrist" in a clinical context. Am J Phys Anthropol. 1971; 35(3):347-52. DOI: 10.1002/ajpa.1330350309. View

20.

Fernandez-Perez L, Guerra B, Diaz-Chico J, Flores-Morales A . Estrogens regulate the hepatic effects of growth hormone, a hormonal interplay with multiple fates. Front Endocrinol (Lausanne). 2013; 4:66. PMC: 3670000. DOI: 10.3389/fendo.2013.00066. View